Impact of low and ultra-low dose estradiol and dydrogesterone on health-related quality of life of postmenopausal women: outcomes from two Phase 3 studies Tommaso Simoncini, Mulan Ren, Tetiana Tatarchuk, Elke Kahler, Qi Yu, John C. Stevenson, Marcelo Graziano Custodio, Junyi Yang, Rossella E. Nappi
A comparison between the anti-Mullerian hormone and ovarian ultrasound for diagnosing polycystic ovary syndrome: A systematic review Nasreen A. Osman
Menopausal hormone therapy and breast cancer risk: 21 years from the WHI clinical studies Carlos Rencoret, José L. Neyro, Santiago Palacios
